Don’t invest unless you’re prepared to lose all your money. These are high-risk investments and you are unlikely to be protected if something goes wrong.
Take 2 mins to learn more
 

Latest News

Latest news and updates directly from our blog.
bt_bb_section_bottom_section_coverage_image
Supporting ClinSpec Diagnostics Ltd

Norcliffe Capital are proud to support ClinSpec Diagnostics Ltd and the future of cancer diagnostics. ClinSpec Dx, a Glasgow based spin out from the University of Strathclyde, have developed a cancer diagnostics system using a simple blood test analysis to accelerate the time it takes to diagnose cancer. Based on the world-leading research of Dr Matthew Baker,...

Completion of a £6 million fundraise for Biosceptre International.

Norcliffe Capital are pleased to announce the completion of a £6 million fundraise for Biosceptre International. Biosceptre International are developing groundbreaking CAR T cancer therapeutics with a unique target that is only found on cancer cells, not normal cells, that should mitigate the usual side effects associated with cancer treatments. Biosceptre is such an exciting...